Voyager Therapeutics logo
Voyager Therapeutics VYGR
$ 5.78 1.58%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Voyager Therapeutics Financial Ratios 2011-2024 | VYGR

Annual Financial Ratios Voyager Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

2.9 -6.1 -1.5 7.6 -9.1 -3.8 -8.1 -7.3 -9.0 - - - -

P/S

1.5 6.9 2.9 1.6 3.8 44.3 56.3 20.7 15.4 - - - -

EPS

3.1 -1.2 -1.9 1.0 -1.2 -2.8 2.6 1.6 9.1 27.8 - - -

EV (Enterprise Value)

432 M 284 M 89.1 M 283 M 566 M 421 M 590 M 312 M 295 M 3.31 M 3.85 M - -

EBITDA per Share

2.94 -1.16 -1.82 0.84 -1.36 -2.77 -2.62 -1.61 -0.788 - - - -

EV/EBITDA

-0.8 5.7 -6.4 -3.3 -7.7 -6.4 -12.0 - - - -

PEG

-0.02 0.05 0.02 -0.96 -0.16 0.92 0.12 2.08 -0.15 - - - -

P/B

1.6 4.8 1.1 1.8 4.0 7.3 4.3 2.2 1.6 - - - -

P/CF

5.0 -22.6 -2.0 -2.9 9.7 -16.7 -8.7 -6.2 6.6 - - - -

ROE %

56.00 -78.63 -74.90 23.81 -43.81 -190.09 -52.74 -29.57 -17.55 - - - -

ROA %

37.67 -29.12 -36.73 14.05 -12.29 -49.87 -38.32 -21.20 -12.93 - - - -

ROCE %

51.63 -86.14 -77.45 17.74 -18.54 -62.67 -42.63 -23.50 -9.85 - - - -

Current Ratio

3.1 1.6 2.0 2.4 4.0 5.1 10.8 13.0 8.2 - - - -

DSO

58.8 1.8 0.5 0.3 66.3 9.6 4.4 59.1 8.7 - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

58.8 1.8 0.5 0.3 - - - - - - - - -

Cash Conversion Cycle

58.8 1.8 0.5 0.3 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Voyager Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.16 -0.18 -0.2 - -0.59 -0.51 3.05 - 0.46 -0.5 -0.56 - -0.67 -0.8 -0.58 - 2.3 -0.23 -0.66 -0.34 -0.41 0.3 -0.81 -0.7 -0.63 -0.8 -0.63 -0.4 -0.89 -0.73 -0.65 0.57 -0.35 -0.37 -0.29 0.67 -5.25 -5.94 -15.79 6.58 -6.45 8.11 6.93 - - - - - - - - - - - -

EBITDA per Share

- - -0.26 - - - 3.05 - 0.51 -0.51 -0.49 - -0.57 -0.76 -0.65 - 2.35 -0.19 -0.64 -0.37 -0.43 0.29 -0.86 -0.72 -0.61 -0.77 -0.65 -0.39 -0.85 -0.69 -0.67 -0.54 -0.39 -0.37 -0.29 -0.3 -3 -3.25 -4.69 -5.52 -5.11 - - - - - - - - - - - - - -

ROE %

-23.78 -35.74 -43.88 31.32 53.40 90.17 69.55 -37.78 -66.54 -117.37 -112.83 -71.90 -16.42 67.81 89.43 34.13 21.49 -49.06 -32.23 -43.81 -79.69 -108.29 -174.49 -190.09 -150.40 -124.13 -83.22 -52.74 -54.71 -43.91 -36.70 -29.57 -23.99 -19.69 -15.12 -18.46 11.71 33.25 35.55 44.18 19.23 - - - - - - - - - - - - - -

ROA %

-15.65 -22.32 -27.03 21.06 30.72 49.16 46.69 -9.36 -22.97 -36.72 -51.15 -37.14 -4.41 41.92 53.03 20.13 16.59 -20.37 -13.91 -12.29 -21.47 -28.70 -46.27 -49.87 -43.56 -44.75 -40.55 -38.32 -39.65 -31.74 -26.44 -21.20 -17.30 -14.27 -11.04 -13.60 -54.96 -88.09 -86.39 -80.04 -34.84 - - - - - - - - - - - - - -

ROCE %

-30.14 -42.72 -51.01 27.12 45.21 80.05 60.57 -42.28 -71.04 -117.90 -111.51 -73.41 -18.64 64.90 84.94 33.12 19.29 -53.38 -38.33 -51.93 -87.96 -115.60 -180.15 -196.13 -155.48 -127.37 -85.95 -53.61 -54.58 -44.79 -37.96 -30.38 -24.60 -19.35 -14.62 -11.98 14.01 33.93 36.28 39.14 17.55 - - - - - - - - - - - - - -

Current Ratio

4.5 4.3 3.6 3.1 2.5 2.7 2.8 1.6 1.8 - 1.5 2.0 1.9 2.1 2.3 2.4 2.4 2.4 2.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 3.7 3.7 3.7 3.7 3.5 3.5 3.5 3.5 3.8 3.8 3.8 3.8 1.1 1.1 - - - - - - - - - - - - - -

DSO

32.7 3.9 189.3 - - - 7.6 - 11.1 - 1.1 - - - 0.7 - - - 1.2 0.7 - - 5.4 14.0 - - 5.9 0.9 - - 10.6 6.5 - - 3.9 3.8 - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

32.7 3.9 189.3 - - - 7.6 - 11.1 - 1.1 - - - 0.7 - - - 1.2 0.7 - - 5.4 14.0 - - 5.9 0.9 - - 10.6 6.5 - - 3.9 3.8 - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

32.7 3.9 189.3 - - - 7.6 - 11.1 - 1.1 - - - 0.7 - - - 1.2 0.7 - - 5.4 14.0 - - 5.9 0.9 - - 10.6 6.5 - - 3.9 3.8 - - - - - - - - - - - - - - - - - - -

All numbers in USD currency